Health Care AngioDynamics Inc. (ANGO) Q2 2021 Earnings Call Transcript 5 years ago AngioDynamics Inc. (NASDAQ: ANGO) Q2 2021 earnings call dated Jan. 07, 2021 Corporate Participants: Jim Clemmer — President and Chief Executive Stephen… Moderna’s (MRNA) stock gains on COVID-19 vaccine approval from the European Commission 5 years ago Shares of Moderna Inc. (NASDAQ: MRNA) gained 6.3% in afternoon hours on Wednesday as the company received approval from the… COVID vaccine: Single-dose regimen can give Johnson & Johnson (JNJ) an edge 5 years ago Johnson & Johnson (NYSE: JNJ) has adopted a slow and steady approach in its COVID vaccine research, which is one… Neogen Corp. (NEOG) Q2 2021 Earnings Call Transcript 5 years ago Neogen Corp. (NASDAQ: NEOG) Q2 2021 earnings call dated Dec. 22, 2020 Corporate Participants: John Adent -- Chief Executive Officer and President… Rite Aid Corporation (RAD) Q3 2021 Earnings Call 5 years ago Rite Aid Corporation (NYSE: RAD) Q3 2021 earnings call dated Dec. 17, 2020. Corporate Participants: Trent Kruse — Senior Vice President, Investor… Rite Aid Corporation (RAD) Q3 2021 Earnings Call Transcript 5 years ago Rite Aid Corporation (NYSE: RAD) Q3 2021 earnings call dated Dec. 17, 2020. Corporate Participants: Trent Kruse -- Senior Vice President, Investor… Infographic: Highlights of Rite Aid’s (RAD) Q3 2021 earnings report 5 years ago Rite Aid Corporation (NYSE: RAD) reported a decline in third-quarter earnings, despite an increase in revenues, as margins were hurt… Eli Lilly (LLY) is paving the way to a strong 2021 5 years ago Shares of Eli Lilly & Co. (NYSE: LLY) were up over 2% on Wednesday. The stock has gained over 30%… Veru Inc. (VERU) Q4 2020 Earnings Call Transcript 5 years ago Veru Inc. (NASDAQ: VERU) Q4 2020 earnings call dated Dec. 09, 2020. Corporate Participants: Samuel Fisch -- Director, Investor Relations Mitchell Steiner -- Chairman,… One key stock you need to track ahead of COVID-19 vaccine approvals 5 years ago It's been a spectacular year for many biotech and pharma investors who have made a killing out of the COVID-19… Is it time to book profits from Moderna? 5 years ago Moderna (NASDAQ: MRNA) stock has soared a staggering 679% since the beginning of this year. If you did identify the… Alexion’s long-term prospects remain intact amid continued focus on rare diseases 5 years ago Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) has stood out in the crowded pharmaceuticals marketplace by developing effective treatments for certain rare health… Veeva Systems Inc. (VEEV) Q3 2021 Earnings Call Transcript 5 years ago Veeva Systems Inc. (NYSE: VEEV) Q3 2021 earnings call dated Dec. 01, 2020 Corporate Participants: Ato Garrett -- Senior Director, Investor Relations… AdaptHealth (AHCO) gains on AeroCare acquisition announcement 5 years ago Shares of AdaptHealth Corp. (NASDAQ: AHCO) surged 15% in morning trade on Tuesday after the company announced its decision to… China Biologic Products Holdings, Inc. (CBPO) Q3 2020 Earnings Call Transcript 5 years ago China Biologic Products Holdings, Inc. (NASDAQ: CBPO) Q3 2020 earnings call dated Nov. 25, 2020. Corporate Participants: Philip Lisio -- Investor Relations,… Is it the right time to invest in Agilent Technologies (A)? 5 years ago Agilent Technologies, Inc. (NYSE: A) ended fiscal 2020 on a positive note, bettering its performance consistently after experiencing a slowdown… Medtronic PLC (MDT) Q2 2021 Earnings Call Transcript 5 years ago Medtronic PLC (NYSE: MDT) Q2 2021 earnings call dated Nov. 24, 2020 Corporate Participants: Ryan Weispfenning -- Vice President - Head of… Infographic: How Medtronic (MDT) performed in Q2 financial results 5 years ago Medtronic plc (NYSE: MDT) reported second quarter 2021 earnings results today. Worldwide revenue was $7.64 billion, down 0.8% on a… Agilent Technologies Inc. (A) Q4 2020 Earnings Call Transcript 5 years ago Agilent Technologies Inc. (NYSE: A) Q4 2020 earnings call dated Nov. 23, 2020 Corporate Participants: Ankur Dhingra -- Vice President of Investor… COVID-19 vaccine: These pharma companies have also made headway 5 years ago The month of November has been huge for pharmaceutical companies with many submitting positive results from their clinical trials for… Current focus is on scaling up capabilities: 10x Genomics CEO Serge Saxonov 5 years ago 10x Genomics, Inc. (NASDAQ: TXG), a pioneer in single-cell genomics, has been eliciting significant investor interest ever since it went… Next» « Previous